We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck announced a national print, television and online advertising campaign to promote and educate consumers about its cervical cancer vaccine Gardasil.
Merck recently disclosed four tax disputes that could cost the company $5.58 billion, adding to the company’s financial burdens as it fights lawsuits over its painkiller Vioxx.
Merck recently disclosed four tax disputes that could cost the company $5.58 billion, adding to the company’s financial burdens as it fights lawsuits over its painkiller Vioxx.
Novartis is taking advantage of China’s inexpensive labor and rapidly growing drug market by building a $100 million research and development center in Shanghai, the company announced.
Forty-three women have filed suit against Ortho-McNeil Pharmaceutical and McKesson alleging the companies misrepresented the known risks associated with the use of Ortho Evra, a birth control skin patch.
Forty-three women have filed suit against Ortho-McNeil Pharmaceutical and McKesson alleging the companies misrepresented the known risks associated with the use of Ortho Evra, a birth control skin patch.
The Centers for Disease Control and Prevention (CDC) has added Merck’s cervical cancer vaccine to its vaccine program for children ages 9–18. Gardasil will now be part of the CDC’s Vaccines for Children (VFC) contract, Merck announced.
The Centers for Disease Control and Prevention (CDC) will evaluate Novavax’s pandemic influenza vaccine, including conducting pre-clinical tests on a live strain of H5N1 bird flu virus, the company said.
A group of medical officials in Washington state has created a proposal that suggests a maximum daily dosage of narcotic painkillers in an attempt to prevent accidental deaths from overdose.